Futermestotug is a humanized immunoglobulin G1-κ monoclonal antibody targeting human cytotoxic T-lymphocyte associated protein 4 ( CTLA4 ). Futermestotug is promising for research of various malignant tumors [1].
References:
[1]. World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
References:
[1]. World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
















